Timed Short Messaging Service Improves Adherence and Virological Outcomes in HIV-1–Infected Patients With Suboptimal Adherence to Antiretroviral Therapy
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
To the Editors: Suboptimal adherence to antiretroviral therapy (ART) is a leading cause of HIV treatment failure.1 Novel interventions targeted at patients with suboptimal adherence are necessary to assure that all HIV-infected persons share the benefits of pharmacotherapy. The use of mobile phone technologies in promoting health behaviors is well documented.2 Short messaging service (SMS) has been utilized successfully as a health promotion tool in diverse contexts, and a number of studies have demonstrated the efficacy of SMS interventions in promoting adherence to ART and outpatient clinical appointments.3–5 As an adherence intervention tool, SMS offers a number of advantages including near universal coverage, low cost, instant delivery, and potential for individualized interventions. Studies in both HIV-negative and HIV-positive subjects show high rates of sustained willingness to receive health-related SMS reminders.6 We designed a multicenter study to investigate the efficacy of a novel intervention: timed SMS reminders. Timed SMS describes the automated delivery of a reminder text message at the time of ART dosing. The efficacy of timed SMS in promoting antiretroviral adherence has not previously been demonstrated. We conducted a single-arm open-label study to investigate the efficacy of timed SMS reminders in improving ART adherence and viroimmunological outcomes amongst suboptimally adherent HIV-infected adults in Italy. The primary outcome was change in self-reported adherence measures over time. Secondary outcomes included change in the proportion of subjects with HIV-1 RNA levels <50 copies per milliliter and the perceived utility of the intervention. The planned intervention and follow-up time was 9 months. Patients receiving HIV care at participating sites were screened for trial eligibility using a validated self-administered adherence questionnaire.7 The following 4 measures of adherence comprised the assessment: (1) proportion of ART doses taken over the preceding month as measured by a visual analogue scale; (2) any missed doses over the past week; (3) variations in dosing schedule >2 hours over the past week; and (4) self-initiated drug interruptions of 2 or more days over the last 3 months. Inclusion in the trial was offered to patients reporting any degree of suboptimal adherence on any measure. Additional inclusion criteria were as follows: age >18 years, receiving ART at time of screening, and access to a mobile phone. The sole exclusion criterion was illiteracy. During the 9-month intervention period, SMS reminders were sent at the time ART dosing, every day including weekends and holidays. SMS reminders were content neutral and contained no mention of HIV, AIDS, ART, or medications. SMS reminders were programmed for automated delivery through a centralized database composed of an anonymous list of subjects, subject cell phone numbers, and dosing schedules. If an SMS could not be delivered within 6 hours of the planned dosing time, delivery was aborted to avoid confusion in dosing schedule. The SMS provider was blinded to the study protocol and hypothesis. Study subjects were evaluated at baseline, 3, 6, and 9 months. An identical self-administered adherence questionnaire was completed at each study visit. ART was prescribed at the discretion of the clinician as part of routine clinical care. Confirmation of each subject's ART regimen and dosing schedule was performed at baseline and at each follow-up visit. Viral load and CD4+ cell count measurements were performed at 3-month intervals, unless otherwise clinically indicated. All subjects continued to receive adherence support as part of routine standard of care, including counseling sessions and psychological support programs already in place at all participating clinical centers. Differences between baseline and subsequent evaluations were assessed by the mean of a paired t test for continuous variables and the McNemar test for categorical variables. The study was designed by the Italian National Institute for Infectious Diseases “L. Spallanzani” Instituto Nationale Malottic Infective in collaboration with Network Persone Sieropositive-Italia Onlus, a patient advocacy group. All subjects provided written informed consent. The study was conducted according to the Good Clinical Practice Guidelines of the European Union and the principles of the Helsinki Declaration. The study was approved by the Institutional Review Boards of all participating centers. One hundred forty-five patients were found eligible for participation, provided written informed consent, and had at least 1 follow-up visit. Subjects were predominantly male (72.8%), older (mean age, 44 years), and treatment experienced (76.9% on second-line or third-line regimens). Median CD4+ cell count at baseline was 384 cells per milliliter (range 238–555) and median HIV-1 RNA level was 1.80 log10 copies per milliliter (range: 1.60–3.25 log10 copies/mL). Figure 1 shows baseline a
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lester, R. T., Ritvo, P., Mills, E. J., Kariri, A., Karanja, S., Chung, M. H., Jack, W., Habyarimana, J., Sadatsafavi, M., Najafzadeh, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61997-6 · Cited by 1,278 · cited 1×
“2 hours over the past week; and (4) self-initiated drug interruptions of 2 or more days over the last 3 months.”
BackgroundPop-Eleches, C., Thirumurthy, H., Habyarimana, J. P., Zivin, J. G., Goldstein, M. P., de Walque, D., MacKeen, L., Haberer, J., Kimaiyo, S., Sidle, J., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834380c1 · Cited by 982
Cited by
Horvath, T., Azman, H., Kennedy, G. E., & Rutherford, G. W. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009756 · Cited by 428
mHealth for HIV Treatment & Prevention: A Systematic Review of the Literature
Catalani, C., Philbrick, W., Fraser, H., Mechael, & Israelski, D. M. (2013) · The Open AIDS Journal · doi:10.2174/1874613620130812003 · Cited by 230
“It is likely that, as the science of mHealth matures, strategies for health systems strengthening and for addressing the HIV prevention and treatment cascade [8,9,38] will increasingly incorporate mobile technologies.”
BackgroundUse of Text Messaging for Maternal and Infant Health: A Systematic Review of the Literature
Poorman, E., Gazmararian, J., Parker, R. M., Yang, B., & Elon, L. (2015) · Maternal and Child Health Journal · doi:10.1007/s10995-014-1595-8 · Cited by 116
Devi, B. R., Syed-Abdul, S., Kumar, A., Iqbal, U., Nguyen, P.-A., Li, Y.-C. (., & Jian, W.-S. (2015) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2015.08.003 · Cited by 110
Amankwaa, I., Boateng, D., Quansah, D. Y., Akuoko, C. P., & Evans, C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204091 · Cited by 98
“[44] requested to withdraw from the study because she felt the intervention Short message services and voice call interventions for antiretroviral therapy adherence”
BackgroundMethodInfluential
Metadata
- Authors
- Ammassari, A., Trotta, M. P., Shalev, N., Tettoni, M. C., Maschi, S., Di Sora, F., Orofino, G., d'Ettorre, G., Bai, F., Celesia, M. B., Roldan, E. Q., Maserati, R., Sterrantino, G., Tommassi, C., Boumis, E., Iardino, M. R., & Antinori, A.
- Venue
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2011-12-01
- Volume
- 58
- Issue
- 4
- Pages
- e113-e115
- ISSN
- 1525-4135 (ISSN-L)
- OpenAlex
- W2319176203
- Cited by
- 24
- References
- 2
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Timed Short Messaging Service Improves Adherence and Virological Outcomes in HIV-1–Infected Patients With Suboptimal Adherence to Antiretroviral Therapy. https://app.cochat.ai/papers/10.1097/qai.0b013e3182359d2a
- The paper
- Ammassari, A., Trotta, M. P., Shalev, N., Tettoni, M. C., Maschi, S., Di Sora, F., Orofino, G., d'Ettorre, G., Bai, F., Celesia, M. B., Roldan, E. Q., Maserati, R., Sterrantino, G., Tommassi, C., Boumis, E., Iardino, M. R., & Antinori, A. (2011). Timed Short Messaging Service Improves Adherence and Virological Outcomes in HIV-1–Infected Patients With Suboptimal Adherence to Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/qai.0b013e3182359d2a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.